Continuous positive airway pressure improves sleep and daytime sleepiness in patients with parkinson disease and sleep apnea

Sleep

Volumn 37, Issue 1, 2014, Pages 177-185

  Neikrug, Ariel B ^a   Liu, Lianqi ^b   Avanzino, Julie A ^b   Maglione, Jeanne E ^b   Natarajan, Loki ^c   Bradley, Lenette ^b   Maugeri, Alex ^b   Corey Bloom, Jody ^d   Palmer, Barton W ^a,b,e   Loredo, Jose S ^f   Ancoli Israel, Sonia ^a,b,e,f  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Continuous positive airway pressure; Daytime sleepiness; Obstructive sleep apnea; Parkinson disease; Sleep disorders; Sleep quality

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PLACEBO; RASAGILINE; SELEGILINE;

AGED; APNEA HYPOPNEA INDEX; AROUSAL INDEX; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAYTIME SOMNOLENCE; FEMALE; HUMAN; MALE; MONOTHERAPY; OXYGEN SATURATION; PARKINSON DISEASE; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP DISORDERED BREATHING; SLEEP LATENCY TEST; SLEEP PARAMETERS; SLEEP QUALITY; SLEEP STAGE; SLEEP TIME; TREATMENT DURATION; TREATMENT OUTCOME;

CONTINUOUS POSITIVE AIRWAY PRESSURE; DAYTIME SLEEPINESS; OBSTRUCTIVE SLEEP APNEA; PARKINSON DISEASE; SLEEP DISORDERS; SLEEP QUALITY;

AGED; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; PARKINSON DISEASE; PLACEBOS; POLYSOMNOGRAPHY; SLEEP; SLEEP APNEA, OBSTRUCTIVE; SLEEP STAGES; TREATMENT OUTCOME;

EID: 84891784184     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.3332     Document Type: Article

References (68)

1. Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988;11:512-9.
2. Gjerstad M, Wentzel-Larsen T, Aarsland D, Larsen J. Insomnia in Parkinson's disease: frequency and progression over time. J Neurol Neurosurg Psychiatry 2007;78:476-9.
3. Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-45.
4. Findley L, Eichhorn T, Janca A, et al. Factors impacting on quality of life in Parkinson's disease: Results from an international survey. Mov Disord 2002;17:60-7.
5. Findley L, Aujla M, Bain PG, et al. Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov Disord 2003;18:1139-45.
6. Bergonzi P. L-dopa plus dopa-decarboxylase inhibitor: Sleep organization in Parkinson's syndrome before and after treatment. Acta Neurol Belg 1975;75:5-10.
7. Friedman A. Sleep pattern in Parkinson's disease. Acta Medica Polona 1980;21:193.
8. Lavie P, Bental E, Goshen H, Sharf B. REM ocular activity in Parkinsonian patients chronically treated with levodopa. J Neural Trans 1980;47:61-7.
9. Mouret J. Differences in sleep in patients with Parkinson's disease. Electroencephalog Clin Neurophysiol 1975;38:653-7.
10. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson's disease and sleepiness an integral part of PD. Neurology 2002;58:1019-24.
11. Zoccolella S, Savarese M, Lamberti P, Manni R, Pacchetti C, Logroscino G. Sleep disorders and the natural history of Parkinson's disease: The contribution of epidemiological studies. Sleep Med Rev 2011;15:41-50.
12. Norlinah M, Afidah K, Noradina A, et al. Sleep disturbances in Malaysian patients with Parkinson's disease using polysomnography and PDSS. Parkinsonism Relat Disord 2009;15:670-4.
13. Cochen De Cock V, Abouda M, Leu S, et al. Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med 2010;11:247-52.
14. Maria B, Sophia S, Michalis M, et al. Sleep breathing disorders in patients with idiopathic Parkinson's disease. Respir Med 2003;97:1151-7.
15. Ancoli-Israel S, Coy T. Are breathing disturbances in elderly equivalent to sleep apnea syndrome? Sleep 1994;17:77-83.
16. Shepard Jr JW. Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med 1992;13:437-58.
17. Redline S, Strauss ME, Adams N, et al. Neuropsychological function in mild sleep-disordered breathing. Sleep 1997;20:160-7.
18. Shpirer I, Miniovitz A, Klein C, et al. Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study. Mov Disord 2006;21:1432-8.
19. Braga-Neto P, Pereira da Silva-Junior F, Sueli Monte F, de Bruin PF, de Bruin V. Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 2004;217:41-5.
20. Ancoli-Israel S, Palmer BW, Cooke JR, et al. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. J Am Geriatr Soc 2008;56:2076-81.
21. Cooke JR, Ancoli-Israel S, Liu L, et al. Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea. Sleep Med 2009;10:1101-6.
22. Loredo JS, Ancoli-Israel S, Kim E-J, Lim WJ, Dimsdale JE. Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study. Sleep 2006;29:564-71.
23. Weaver TE, Chasens ER. Continuous positive airway pressure treatment for sleep apnea in older adults. Sleep Med Rev 2007;11:99-111.
24. Simpson G, Angus J. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970;45:11-9.
25. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-9.
26. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Holstein N, eds. Recent developments in Parkinson's disease. Vol. 2. Plurham Park, NJ: Macmillian Healthcare Information, 1987:153-63.
27. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. 1967. Neurology 1998;50:318 and 16 pages following.
28. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations the Movement Disorder Society Task Force on rating scales for Parkinson's disease. Mov Disord 2004;19:1020-8.
29. Iber C, Ancoli-Israel S, Chesson A, Quan SF. The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specifications. Westchester, IL: American Academy of Sleep Medicine, 2007.
30. Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005;28:113-21.
31. Farré R, Hernández L, Montserrat JM, Rotger M, Ballester E, Navajas D. Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea. Lancet 1999;353:1154.
32. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-53.
33. Diggle P, Heagerty P, Liang KY, Zeger S. Analysis of longitudinal data. 2nd ed. New York, NY: Oxford University Press Inc., 2002.
34. Reeves-Hoche MK, Meck R, Zwillich CW. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 1994;149:149-54.
35. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147:887-95.
36. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea. A population-based study. Chest 2002;121:430-5.
37. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998;13:895-9.
38. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999;14:922-7.
39. Garcia-Borreguero D, Larrosa O, Bravo M. Parkinson's disease and sleep. Sleep Med Rev 2003;7:115-29.
40. American Academy of Sleep Medicine. International classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine, 2005.
41. Covassin N, Neikrug AB, Liu LQ, et al. Relationships between clinical characteristics and nocturnal cardiac autonomic activity in Parkinson's disease. Auton Neurosci 2012;171:85-8.
42. McGinty D, Szymusiak R. Keeping cool: a hypothesis about the mechanisms and functions of slow-wave sleep. Trends Neurosci 1990;13:480-7.
43. Van Der Werf YD, Altena E, Schoonheim MM, et al. Sleep benefits subsequent hippocampal functioning. Nature Neurosci 2009;12:122-3.
44. Bonsignore G, Marrone O, Bellia V, Giannone G, Ferrara G, Milone F. Continuous positive airway pressure improves the quality of sleep and oxygenation in obstructive sleep apnea syndrome. Italian J Neurol Sci 1987;8:129-34.
45. Lamphere J, Roehrs T, Wittig R, Zorick F, Conway W, Roth T. Recovery of alertness after CPAP in apnea. Chest 1989;96:1364-7.
46. Fietze I, Quispe-Bravo S, Hansch T, Rottig J, Baumann G, Witt C. Arousals and sleep stages in patients with obstructive sleep apnoea syndrome: Changes under nCPAP treatment. J Sleep Res 1997;6:128-33.
47. Collard P, Dury M, Delguste P, Aubert G, Rodenstein DO. Movement arousals and sleep-related disordered breathing in adults. Am J Respir Crit Care Med 1996;154:454-9.
48. Verma A, Radtke RA, VanLandingham KE, King JH, Husain AM. Slow wave sleep rebound and REM rebound following the first night of treatment with CPAP for sleep apnea: correlation with subjective improvement in sleep quality. Sleep Med 2001;2:215-23.
49. Brillante R, Cossa G, Liu PY, Laks L. Rapid eye movement and slowwave sleep rebound after one night of continuous positive airway pressure for obstructive sleep apnoea. Respirology 2012;17:547-53.
50. Habukawa M, Uchimura N, Kakuma T, et al. Effect of CPAP treatment on residual depressive symptoms in patients with major depression and coexisting sleep apnea: Contribution of daytime sleepiness to residual depressive symptoms. Sleep Med 2010;11:552-7.
51. Engleman H, Martin S, Douglas N, Deary I. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994;343:572-5.
52. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in" non-dippers". Sleep 1996;19:378-81.
53. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997;52:114-9.
54. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.
55. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001;164:1459-63.
56. Ballester E, Badia JR, Hernandez L, et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/ hypopnea syndrome. Am J Respir Crit Care Med 1999;159:495-501.
57. Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998;157:858-65.
58. Montserrat JM, Ferrer M, Hernandez L, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001;164:608-13.
59. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100-5.
60. Hack M, Davies RJ, Mullins R, et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea. Thorax 2000;55:224-31.
61. Bardwell WA, Ancoli-Israel S, Berry CC, Dimsdale JE. Neuropsychological effects of one-week continuous positive airway pressure treatment in patients with obstructive sleep apnea: a placebocontrolled study. Psychosom Med 2001;63:579-84.
62. Profant J, Ancoli-Israel S, Dimsdale JE. A randomized, controlled trial of 1 week of continuous positive airway pressure treatment on quality of life. Heart Lung 2003;32:52-8.
63. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999;116:1545-9.
64. Rodway GW, Weaver TE, Mancini C, et al. Evaluation of sham-CPAP as a placebo in CPAP intervention studies. Sleep 2010;33:260.
65. Diederich NJ, Vaillant M, Leischen M, et al. Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients. Mov Disord 2005;20:1413-8.
66. Trotti LM, Bliwise DL. No increased risk of obstructive sleep apnea in Parkinson's disease. Mov Disord 2010;25:2246-9.
67. Mehra R, Stone KL, Blackwell T, et al. Prevalence and correlates of seepdisordered breathing in older men: Osteoporotic Fractures in Men Sleep Study. J Am Geriatr Soc 2007;55:1356-64.
68. Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991;14:486.